United States Hypertension Drugs Market Report 2018

February 2018 | 102 pages | ID: UC31AF06413EN
QYResearch

Abstracts

In this report, the United States Hypertension Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Hypertension Drugs in these regions, from 2013 to 2025 (forecast).

United States Hypertension Drugs market competition by top manufacturers/players, with Hypertension Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Daiichi Sankyo
• Actelion Pharmaceuticals
• Boehringer Ingelheim
• Sanofi
• Pfizer
• Actelion Pharmaceuticals
• Bayer
• Johnson & Johnson
• Merck

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Systemic hypertension drugs
• Pulmonary hypertension drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Drugstore
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Hypertension Drugs Market Report 2018

1 HYPERTENSION DRUGS OVERVIEW

1.1 Product Overview and Scope of Hypertension Drugs
1.2 Classification of Hypertension Drugs by Product Category
  1.2.1 United States Hypertension Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Hypertension Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Systemic hypertension drugs
  1.2.4 Pulmonary hypertension drugs
1.3 United States Hypertension Drugs Market by Application/End Users
  1.3.1 United States Hypertension Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Hypertension Drugs Market by Region
  1.4.1 United States Hypertension Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Hypertension Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Hypertension Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Hypertension Drugs Status and Prospect (2013-2025)
  1.4.5 New England Hypertension Drugs Status and Prospect (2013-2025)
  1.4.6 The South Hypertension Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Hypertension Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Hypertension Drugs (2013-2025)
  1.5.1 United States Hypertension Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Hypertension Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES HYPERTENSION DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hypertension Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Hypertension Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Hypertension Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Hypertension Drugs Market Competitive Situation and Trends
  2.4.1 United States Hypertension Drugs Market Concentration Rate
  2.4.2 United States Hypertension Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hypertension Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HYPERTENSION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Hypertension Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Hypertension Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Hypertension Drugs Price by Region (2013-2018)

4 UNITED STATES HYPERTENSION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Hypertension Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Hypertension Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Hypertension Drugs Price by Type (2013-2018)
4.4 United States Hypertension Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HYPERTENSION DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Hypertension Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Hypertension Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HYPERTENSION DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hypertension Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo
  6.2.2 Hypertension Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Actelion Pharmaceuticals
  6.3.2 Hypertension Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Actelion Pharmaceuticals Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
  6.4.2 Hypertension Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Hypertension Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Hypertension Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Actelion Pharmaceuticals
  6.7.2 Hypertension Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actelion Pharmaceuticals Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.2 Hypertension Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Johnson & Johnson
  6.9.2 Hypertension Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Johnson & Johnson Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.2 Hypertension Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Hypertension Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 HYPERTENSION DRUGS MANUFACTURING COST ANALYSIS

7.1 Hypertension Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hypertension Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hypertension Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hypertension Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HYPERTENSION DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Hypertension Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Hypertension Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Hypertension Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Hypertension Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hypertension Drugs
Figure United States Hypertension Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Hypertension Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Systemic hypertension drugs Product Picture
Figure Pulmonary hypertension drugs Product Picture
Figure United States Hypertension Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Hypertension Drugs by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Hypertension Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Hypertension Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Hypertension Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Hypertension Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Hypertension Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Hypertension Drugs Sales Share by Players/Suppliers
Figure 2017 United States Hypertension Drugs Sales Share by Players/Suppliers
Figure United States Hypertension Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Hypertension Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Hypertension Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Hypertension Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Hypertension Drugs Revenue Share by Players/Suppliers
Table United States Market Hypertension Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Hypertension Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Hypertension Drugs Market Share of Top 3 Players/Suppliers
Figure United States Hypertension Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hypertension Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hypertension Drugs Product Category
Table United States Hypertension Drugs Sales (K Units) by Region (2013-2018)
Table United States Hypertension Drugs Sales Share by Region (2013-2018)
Figure United States Hypertension Drugs Sales Share by Region (2013-2018)
Figure United States Hypertension Drugs Sales Market Share by Region in 2017
Table United States Hypertension Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Hypertension Drugs Revenue Share by Region (2013-2018)
Figure United States Hypertension Drugs Revenue Market Share by Region (2013-2018)
Figure United States Hypertension Drugs Revenue Market Share by Region in 2017
Table United States Hypertension Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Hypertension Drugs Sales (K Units) by Type (2013-2018)
Table United States Hypertension Drugs Sales Share by Type (2013-2018)
Figure United States Hypertension Drugs Sales Share by Type (2013-2018)
Figure United States Hypertension Drugs Sales Market Share by Type in 2017
Table United States Hypertension Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Hypertension Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Hypertension Drugs by Type (2013-2018)
Figure Revenue Market Share of Hypertension Drugs by Type in 2017
Table United States Hypertension Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Hypertension Drugs Sales Growth Rate by Type (2013-2018)
Table United States Hypertension Drugs Sales (K Units) by Application (2013-2018)
Table United States Hypertension Drugs Sales Market Share by Application (2013-2018)
Figure United States Hypertension Drugs Sales Market Share by Application (2013-2018)
Figure United States Hypertension Drugs Sales Market Share by Application in 2017
Table United States Hypertension Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Hypertension Drugs Sales Growth Rate by Application (2013-2018)
Table Novartis Basic Information List
Table Novartis Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Novartis Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Bayer Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Bayer Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Hypertension Drugs Sales Growth Rate (2013-2018)
Figure Merck Hypertension Drugs Sales Market Share in United States (2013-2018)
Figure Merck Hypertension Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hypertension Drugs
Figure Manufacturing Process Analysis of Hypertension Drugs
Figure Hypertension Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hypertension Drugs Major Players/Suppliers in 2017
Table Major Buyers of Hypertension Drugs
Table Distributors/Traders List
Figure United States Hypertension Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Hypertension Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Hypertension Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Hypertension Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Hypertension Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Hypertension Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Hypertension Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Hypertension Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Hypertension Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Hypertension Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Hypertension Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Hypertension Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Hypertension Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources